WINTER 2012

Eye on risk

The latest buzz in clinical research is 'risk-based monitoring'. Describing a project management approach that focuses only on the most important data, it is seeing a surge of adoptees throughout the industry. Shantal Feltham, president and CEO of Stiris Research, explains the probable benefits while counselling caution.
More..

SUMMER 2012

Utilisation of Genomic Signatures in Drug Development In the current economic climate there is more pressure than ever on the pharma industry to provide safe and effective medicines in as short a timescale as possible.
More..